Sexual dysfunction affects more than two-thirds of individuals with chronic kidney disease (CKD), making it a highly prevalent yet often overlooked complication. Its prevalence varies according to treatment modality, with kidney transplant recipients experiencing lower rates than patients receiving other forms of CKD treatment. The condition is strongly associated with reduced quality of life and greater severity of depression. These findings highlight the importance of routine screening for sexual health concerns and the integration of psychological and sexual health support into comprehensive CKD care.
Sexual dysfunction in chronic kidney disease (CKD) is frequently underrecognized and underreported worldwide, despite its well-established association with depression and reduced quality of life (QoL). This study estimated the pooled global prevalence of sexual dysfunction among individuals with CKD and evaluated its impact on psychosocial well-being.
A systematic review and meta-analysis of published studies examining sexual dysfunction in CKD was conducted following PRISMA 2020 guidelines. Pooled prevalence estimates were calculated using a DerSimonian-Laird random-effects model with Freeman-Tukey double arcsine transformation, and correlation coefficients were pooled following Fisher’s Z transformation.
Forty-four eligible studies, involving 10,672 participants from 18 countries, were included. The overall pooled prevalence of sexual dysfunction was 71.2% (95% CI: 65.9–76.3%, I²= 96.8%), with no significant difference across geographical regions (p = 0.87) or between males and females. Prevalence was significantly higher among patients on hemodialysis (77.6%) and those in the predialysis stage (76.7%) compared with post-kidney transplant recipients (56.9%), with a significant difference across patient groups (p = 0.01). Sexual dysfunction was significantly correlated with poorer mental and physical health-related quality of life, as well as greater depression severity as measured by the IIEF and FSFI. No significant publication bias was observed on Begg’s test (p = 0.48) or Egger’s test (p = 0.16).
Sexual dysfunction is highly prevalent among individuals with CKD, affecting more than two-thirds of patients and varying by treatment modality, with lower prevalence observed after kidney transplantation. It is significantly associated with poorer quality of life and depression severity. These findings underscore the need for routine screening and integrated psychological and sexual health interventions in CKD care.
Reference:
Edeki, I.R., Adejumo, O.A., Oyedepo, D.S. et al. Sexual dysfunction and effect on quality of life in chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol (2026). https://doi.org/10.1186/s12882-026-05142-2
Keywords:
Sexual, Dysfunction, Common, Chronic Kidney Disease, Linked, Poorer Quality of Life, Study, Edeki, I.R., Adejumo, O.A., Oyedepo, D.S.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.